MVIR:STO
Medivir AB
1,51 SEK
arrow_upward
+0,80%(+0,012) 1 d.
12. 10., 17:29:47 GMT+2 · SEK
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre MVIR…
Otvoriť
1,49 SEK
Vysoká
1,51 SEK
Nízka
1,46 SEK
Trh. kap.
942,54 mil.
Priem. obj.
1,45 mil.
Objem
1,55 mil.
Max. za 52 týž.
2,88 SEK
Min. za 52 týž.
0,34 SEK
Výnosy na akciu
-0,37 SEK
Akcie v obehu
624,18 mil.
Počet zamestnancov
6
Otvoriť
1,49 SEK
Vysoká
1,51 SEK
Nízka
1,46 SEK
Trh. kap.
942,54 mil.
Priem. obj.
1,45 mil.
Objem
1,55 mil.
Max. za 52 týž.
2,88 SEK
Min. za 52 týž.
0,34 SEK
Výnosy na akciu
-0,37 SEK
Akcie v obehu
624,18 mil.
Počet zamestnancov
6
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
The Business Journals
·
pred 40 minútami
FirstBank CEO rings NYSE bell a decade after IPO as lender eyes future
CNBC
·
pred 40 minútami
The bull market turned 4 years old on Monday. Investors say reaching a fifth birthday could be challenging
kalkine.ca
·
pred 54 minútami
Which of ProFunds UltraSector Energy (NASDAQ:ENPIX), Vanguard Energy Index Admiral (NASDAQ:VENAX), Fidelity Select Energy (NASDAQ:FSENX), BlackRock Energy Opportunities Instl (NASDAQ:BACIX) or Invesco Discovery Mid Cap Growth R5 (NASD
Yahoo Finance
·
pred 5 hodinami
A handful of tech stocks are masking an ugly S&P 500 problem
Profil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Informácie o subjekte Medivir AB